ADVFN ADVFN

Hot Features

Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
OncoSec Medical Incorporated (EM)

OncoSec Medical Incorporated (EM) (ONCSQ)

0.000001
0.00
(0.00%)
終了 6月11日 5:00AM

OncoSec Medical Incorporated (EM) (ONCSQ) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.000001
( - )
買値
0.00
売値
0.00
出来高
-
0.00 日の範囲 0.00
0.000001 52 週間の範囲 0.0001
時価総額
前日終値
0.000001
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 1,623
発行済株式数
5,962,652
配当利回り
PER
-
1 株当たり利益 (EPS)
-14.77
歳入
-
純利益
-29.39M

OncoSec Medical Incorporated (EM) について

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company’s product pipeline includes KEYNOTE-695, which is i... OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company’s product pipeline includes KEYNOTE-695, which is in Phase 2 trial for the treatment of advanced melanoma; TAVO + SARS-CoV-2 spike glycoprotein, which is in Phase 1 clinical trial for the treatment of COVID-19; and TAVO + epacadostat + pembrolizumab, which is in Phase 1 clinical trial for the treatment of squamous cell carcinoma head and neck cancer. Its pipeline also comprises TAVO +nivolumab, which is in Phase 2 clinical trial for the treatment of breast cancer; TAVO + CXCL9 for the treatment of solid tumors; and OMS-100 and OMS-102, which are in Phase 2 clinical trial for the treatment of metastatic melanoma. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890; and a research collaboration with Duke University’s Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was incorporated in 2008 and is headquartered in Pennington, New Jersey. On June 14, 2023, OncoSec Medical Incorporated filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of New Jersey. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Pennington, United States
設立
2026
OncoSec Medical Incorporated (EM) is listed in the Healthcare sector of the その他OTC with ticker ONCSQ. The last closing price for OncoSec Medical (EM) was US$0. Over the last year, OncoSec Medical (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.0001.

OncoSec Medical (EM) currently has 5,962,652 shares in issue. The market capitalisation of OncoSec Medical (EM) is US$5.96 . OncoSec Medical (EM) has a price to earnings ratio (PE ratio) of 0.

ONCSQ 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1001.0E-61.0E-61.0E-62791.0E-6CS
4001.0E-61.0E-61.0E-62791.0E-6CS
12001.0E-61.0E-61.0E-69741.0E-6CS
26001.0E-60.00011.0E-627377.919E-5CS
52001.0E-60.00011.0E-6135149.517E-5CS
156-0.179999-99.99944444440.180.231.0E-6394110.10203841CS
260-0.179999-99.99944444440.180.231.0E-6394110.10203841CS

ONCSQ - Frequently Asked Questions (FAQ)

What is the current OncoSec Medical Incorporated (EM) share price?
The current share price of OncoSec Medical Incorporated (EM) is US$ 0.000001
How many OncoSec Medical Incorporated (EM) shares are in issue?
OncoSec Medical Incorporated (EM) has 5,962,652 shares in issue
What is the market cap of OncoSec Medical Incorporated (EM)?
The market capitalisation of OncoSec Medical Incorporated (EM) is USD 5.96
What is the 1 year trading range for OncoSec Medical Incorporated (EM) share price?
OncoSec Medical Incorporated (EM) has traded in the range of US$ 0.000001 to US$ 0.0001 during the past year
What is the registered address of OncoSec Medical Incorporated (EM)?
The registered address for OncoSec Medical Incorporated (EM) is 24 North Main Street, Pennington, New Jersey, 08534
What is the OncoSec Medical Incorporated (EM) website address?
The website address for OncoSec Medical Incorporated (EM) is oncosec.com
Which industry sector does OncoSec Medical Incorporated (EM) operate in?
OncoSec Medical Incorporated (EM) operates in the Biotechnology & Life Sciences sector

ONCSQ 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

ONCSQ Discussion

投稿を表示